drugset / Trial / NCT03608592

Human Umbilical Cord Mesenchymal Stem Cells (MSCs) Therapy in ARDS

NCT03608592

Unknown 26 enrolled Sun Yat-sen University
NaSingle-groupOpen-labelTreatment

Summary

Acute respiratory distress syndrome (ARDS) is a devastating inflammatory and destructive disease in critical ill patients. Preclinical studies have shown a promising perspective of mesenchymal stem cells (MSCs) therapies in ARDS. But the safety and efficacy of umbilical cord MSCs (UCMSCs) have not yet been convinced in clinical trails. This study will explore the safety and life-rescue potential of UCMSCs in refracotry ARDS.

Timeline

Start
2018-06-01
Primary completion
2020-08-01
Completion
2020-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 1e+06 cells/kg Intravenous